HLSCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,010 KRW | +0.07% |
|
-0.07% | -12.11% |
| Sales 2022 | 52.76B 38.36M | Sales 2023 | 25.59B 18.6M | Capitalization | 81.18B 59.02M |
|---|---|---|---|---|---|
| Net income 2022 | 1.59B 1.16M | Net income 2023 | -1.38B -1M | EV / Sales 2022 | 1.29 x |
| Net cash position 2022 | 29.34B 21.33M | Net cash position 2023 | 28.62B 20.8M | EV / Sales 2023 | 2.05 x |
| P/E ratio 2022 |
61.2
x | P/E ratio 2023 |
-59
x | Employees | 76 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 31.2% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.07% | ||
| 1 week | -0.07% | ||
| Current month | +0.79% | ||
| 1 month | -8.49% | ||
| 3 months | -0.14% | ||
| 6 months | -9.90% | ||
| Current year | -12.11% |
1 week
13 830.00
16 550.00
1 month
13 630.0016 550.00
Current year
13 050.0018 200.00
1 year
11 300.0018 200.00
3 years
11 300.0040 350.00
5 years
11 300.0092 380.95
10 years
11 300.00113 904.76
| Managers | Title | Age | Since |
|---|---|---|---|
Hae-Yeon Lee
CEO | Chief Executive Officer | 55 | 00-09-27 |
Dong-Ryul Lee
BRD | Director/Board Member | 45 | 05-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hae-Yeon Lee
CEO | Chief Executive Officer | 55 | 00-09-27 |
Dong-Ryul Lee
BRD | Director/Board Member | 45 | 05-04-30 |
Dong-Wu Choi
BRD | Director/Board Member | 46 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-12 | 14,010 | +0.07% | 4,452 |
| 24-07-11 | 14,000 | -1.13% | 6,701 |
| 24-07-10 | 14,160 | -0.14% | 7,029 |
| 24-07-09 | 14,180 | +0.85% | 15,246 |
| 24-07-08 | 14,060 | +0.29% | 446,920 |
End-of-day quote Korea S.E., July 11, 2024
More quotes
HLscience Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of healthcare products. The company manufactures products in the areas of live health, climacteric women health, stomach health, antioxidant/skin health, immunity, blood circulation improvement, eye health, intestinal health, articulation health, fatigue/stamina, diet, antioxidant/immunity, multi-vitamin/mineral/calcium, male health and general foods. The Company distributes its productions within domestic market and to overseas markets.
Sector
Food Processing
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -12.11% | 51.92M | |
| +20.34% | 8.65B | |
| -0.67% | 7.18B | |
| -18.41% | 4.82B | |
| -7.42% | 3.67B | |
| -21.73% | 3.13B | |
| -16.84% | 1.14B | |
| -29.29% | 1.08B | |
| -1.36% | 954M | |
| -15.47% | 863M |
- Stock Market
- Equities
- A239610 Stock
